American Well

Budget Cuts And Data Rules Will Cripple Healthcare Margins

AnalystLowTarget

Not Invested

Community Contributor

Published

13 Aug 25

AnalystLowTarget's Fair Value

US$7.50

27.3% undervalued

13 Aug

US$5.45

-47.3%

-6.4%

-47.3%

-6.4%

You can edit this narrative until Aug 13 10:11 PM. Then, changes will post as Updates.

Author's Valuation

US$7.527.3% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$7.5

27.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

1.53%

Healthtech revenue growth rate

8.62%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.06%

Calculation

US$21.20m

Earnings '28

8.99x

PE Ratio '28

US$190.53m

Market Cap '28

US$190.53m

Market Cap '28

20.20m

No. shares '28

US$9.43

Share Price '28

US$9.43 Share Price '28

Discounted to 2025 @ 7.93% p.a.

US$7.50

Fair Value '25